Yaben (Shaoxing) Pharmaceutical Co., Ltd.
8 signals · 8 added · 0 dropped or cut · 0 intermediate projects
Plants in our filings
- Industrial Expansion Area, Hangzhou Bay Shangyu Economic and Technological Development Zone, Shaoxing, Zhejiang
Signals
| Filing | Molecule | Signal | Stage | t / year | Source |
|---|---|---|---|---|---|
| Oct 2026 | Sevelamer | ↑ NEW PLANT | EIA approved | +200 | Shaoxing Ecology and Environment Bureau, pre-approval notice |
| Oct 2026 | Levetiracetam | ↑ NEW PLANT | EIA approved | +50 | Shaoxing Ecology and Environment Bureau, pre-approval notice |
| Oct 2026 | Cilastatin | ↑ NEW PLANT | EIA approved | +50 | Shaoxing Ecology and Environment Bureau, pre-approval notice |
| Oct 2026 | Atazanavir | ↑ NEW PLANT | EIA approved | +40 | Shaoxing Ecology and Environment Bureau, pre-approval notice |
| Oct 2026 | Brivaracetam | ↑ NEW PLANT | EIA approved | +15 | Shaoxing Ecology and Environment Bureau, pre-approval notice |
| Oct 2026 | Nebivolol | ↑ NEW PLANT | EIA approved | +10 | Shaoxing Ecology and Environment Bureau, pre-approval notice |
| Oct 2026 | Vemurafenib | ↑ NEW PLANT | EIA approved | +10 | Shaoxing Ecology and Environment Bureau, pre-approval notice |
| Oct 2026 | Apixaban | ↑ NEW PLANT | EIA approved | +2 | Shaoxing Ecology and Environment Bureau, pre-approval notice |
Need an alternative supplier?
Find current manufacturers for any molecule, with US DMF and CEP status and contacts, in the api-fdf.com database.